Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Non-steroidal Anti-inflammatory Drugs (NSAID) in global, including the following market information:
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Non-steroidal Anti-inflammatory Drugs (NSAID) companies in 2021 (%)
The global Non-steroidal Anti-inflammatory Drugs (NSAID) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Salicylates Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) include Bayer, Ecotrin, Generic, St. Joseph, Elanco, Zoetis, Boehringer Ingelheim, Merial and Merck Animal Health. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-steroidal Anti-inflammatory Drugs (NSAID) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segment Percentages, by Type, 2021 (%)
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segment Percentages, by Application, 2021 (%)
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) revenues share in global market, 2021 (%)
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Non-steroidal Anti-inflammatory Drugs (NSAID) companies in 2021 (%)
The global Non-steroidal Anti-inflammatory Drugs (NSAID) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Salicylates Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) include Bayer, Ecotrin, Generic, St. Joseph, Elanco, Zoetis, Boehringer Ingelheim, Merial and Merck Animal Health. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-steroidal Anti-inflammatory Drugs (NSAID) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segment Percentages, by Type, 2021 (%)
- Salicylates
- Propionic acid derivatives
- Acetic acid derivatives
- Enolic acid (Oxicam) derivatives
- Anthranilic acid derivatives (Fenamates)
- Selective COX-2 inhibitors (Coxibs)
- Sulfonanilides
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segment Percentages, by Application, 2021 (%)
- Human
- Animals
- Others
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) revenues share in global market, 2021 (%)
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bayer
- Ecotrin
- Generic
- St. Joseph
- Elanco
- Zoetis
- Boehringer Ingelheim
- Merial
- Merck Animal Health
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) OVERALL MARKET SIZE
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size: 2021 VS 2028
2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market
3.2 Top Global Non-steroidal Anti-inflammatory Drugs (NSAID) Companies Ranked by Revenue
3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Companies
3.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Companies
3.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market
3.8.1 List of Global Tier 1 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Markets, 2021 & 2028
4.1.2 Salicylates
4.1.3 Propionic acid derivatives
4.1.4 Acetic acid derivatives
4.1.5 Enolic acid (Oxicam) derivatives
4.1.6 Anthranilic acid derivatives (Fenamates)
4.1.7 Selective COX-2 inhibitors (Coxibs)
4.1.8 Sulfonanilides
4.2 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
4.2.1 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2022
4.2.2 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2023-2028
4.2.3 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
4.3 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
4.3.1 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2022
4.3.2 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2023-2028
4.3.3 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
4.4 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2021 & 2028
5.1.2 Human
5.1.3 Animals
5.1.4 Others
5.2 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
5.2.1 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2022
5.2.2 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2023-2028
5.2.3 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
5.3 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
5.3.1 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2022
5.3.2 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2023-2028
5.3.3 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
5.4 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2021 & 2028
6.2 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
6.2.1 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2022
6.2.2 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2023-2028
6.2.3 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
6.3 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
6.3.1 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2022
6.3.2 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2023-2028
6.3.3 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
6.4.2 By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
6.4.3 US Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.4.4 Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.4.5 Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
6.5.2 By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
6.5.3 Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5.4 France Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5.5 U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5.6 Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5.7 Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5.8 Nordic Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5.9 Benelux Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
6.6.2 By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
6.6.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.6.4 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.6.5 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.6.6 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.6.7 India Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
6.7.2 By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
6.7.3 Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.7.4 Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
6.8.3 Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.8.4 Israel Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.8.5 Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.8.6 UAE Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.1.5 Bayer Key News
7.2 Ecotrin
7.2.1 Ecotrin Corporate Summary
7.2.2 Ecotrin Business Overview
7.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.2.5 Ecotrin Key News
7.3 Generic
7.3.1 Generic Corporate Summary
7.3.2 Generic Business Overview
7.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.3.5 Generic Key News
7.4 St. Joseph
7.4.1 St. Joseph Corporate Summary
7.4.2 St. Joseph Business Overview
7.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.4.5 St. Joseph Key News
7.5 Elanco
7.5.1 Elanco Corporate Summary
7.5.2 Elanco Business Overview
7.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.5.5 Elanco Key News
7.6 Zoetis
7.6.1 Zoetis Corporate Summary
7.6.2 Zoetis Business Overview
7.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.6.5 Zoetis Key News
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Corporate Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.7.5 Boehringer Ingelheim Key News
7.8 Merial
7.8.1 Merial Corporate Summary
7.8.2 Merial Business Overview
7.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.8.5 Merial Key News
7.9 Merck Animal Health
7.9.1 Merck Animal Health Corporate Summary
7.9.2 Merck Animal Health Business Overview
7.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.9.5 Merck Animal Health Key News
8 GLOBAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) PRODUCTION CAPACITY, ANALYSIS
8.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity, 2017-2028
8.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) SUPPLY CHAIN ANALYSIS
10.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Value Chain
10.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Upstream Market
10.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) OVERALL MARKET SIZE
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size: 2021 VS 2028
2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market
3.2 Top Global Non-steroidal Anti-inflammatory Drugs (NSAID) Companies Ranked by Revenue
3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Companies
3.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Companies
3.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market
3.8.1 List of Global Tier 1 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Markets, 2021 & 2028
4.1.2 Salicylates
4.1.3 Propionic acid derivatives
4.1.4 Acetic acid derivatives
4.1.5 Enolic acid (Oxicam) derivatives
4.1.6 Anthranilic acid derivatives (Fenamates)
4.1.7 Selective COX-2 inhibitors (Coxibs)
4.1.8 Sulfonanilides
4.2 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
4.2.1 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2022
4.2.2 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2023-2028
4.2.3 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
4.3 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
4.3.1 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2022
4.3.2 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2023-2028
4.3.3 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
4.4 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2021 & 2028
5.1.2 Human
5.1.3 Animals
5.1.4 Others
5.2 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
5.2.1 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2022
5.2.2 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2023-2028
5.2.3 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
5.3 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
5.3.1 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2022
5.3.2 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2023-2028
5.3.3 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
5.4 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2021 & 2028
6.2 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
6.2.1 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2022
6.2.2 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2023-2028
6.2.3 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
6.3 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
6.3.1 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2022
6.3.2 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2023-2028
6.3.3 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
6.4.2 By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
6.4.3 US Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.4.4 Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.4.5 Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
6.5.2 By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
6.5.3 Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5.4 France Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5.5 U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5.6 Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5.7 Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5.8 Nordic Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.5.9 Benelux Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
6.6.2 By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
6.6.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.6.4 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.6.5 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.6.6 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.6.7 India Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
6.7.2 By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
6.7.3 Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.7.4 Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
6.8.3 Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.8.4 Israel Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.8.5 Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
6.8.6 UAE Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.1.5 Bayer Key News
7.2 Ecotrin
7.2.1 Ecotrin Corporate Summary
7.2.2 Ecotrin Business Overview
7.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.2.5 Ecotrin Key News
7.3 Generic
7.3.1 Generic Corporate Summary
7.3.2 Generic Business Overview
7.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.3.5 Generic Key News
7.4 St. Joseph
7.4.1 St. Joseph Corporate Summary
7.4.2 St. Joseph Business Overview
7.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.4.5 St. Joseph Key News
7.5 Elanco
7.5.1 Elanco Corporate Summary
7.5.2 Elanco Business Overview
7.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.5.5 Elanco Key News
7.6 Zoetis
7.6.1 Zoetis Corporate Summary
7.6.2 Zoetis Business Overview
7.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.6.5 Zoetis Key News
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Corporate Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.7.5 Boehringer Ingelheim Key News
7.8 Merial
7.8.1 Merial Corporate Summary
7.8.2 Merial Business Overview
7.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.8.5 Merial Key News
7.9 Merck Animal Health
7.9.1 Merck Animal Health Corporate Summary
7.9.2 Merck Animal Health Business Overview
7.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
7.9.5 Merck Animal Health Key News
8 GLOBAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) PRODUCTION CAPACITY, ANALYSIS
8.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity, 2017-2028
8.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) SUPPLY CHAIN ANALYSIS
10.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Value Chain
10.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Upstream Market
10.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Non-steroidal Anti-inflammatory Drugs (NSAID) in Global Market
Table 2. Top Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Companies, 2017-2022
Table 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Companies, (K Units), 2017-2022
Table 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
Table 9. List of Global Tier 1 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2017-2022
Table 15. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2023-2028
Table 16. By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2017-2022
Table 20. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2023-2028
Table 21. By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2017-2022
Table 25. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2023-2028
Table 26. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2017-2022
Table 29. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2023-2028
Table 30. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2017-2022
Table 33. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2023-2028
Table 34. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2017-2022
Table 37. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2023-2028
Table 38. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2017-2022
Table 41. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2023-2028
Table 46. Bayer Corporate Summary
Table 47. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 48. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Ecotrin Corporate Summary
Table 50. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 51. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Generic Corporate Summary
Table 53. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 54. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. St. Joseph Corporate Summary
Table 56. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 57. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Elanco Corporate Summary
Table 59. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 60. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Zoetis Corporate Summary
Table 62. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 63. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Boehringer Ingelheim Corporate Summary
Table 65. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 66. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Merial Corporate Summary
Table 68. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 69. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Merck Animal Health Corporate Summary
Table 71. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 72. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 74. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production by Region, 2017-2022 (K Units)
Table 76. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production by Region, 2023-2028 (K Units)
Table 77. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Opportunities & Trends in Global Market
Table 78. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers in Global Market
Table 79. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints in Global Market
Table 80. Non-steroidal Anti-inflammatory Drugs (NSAID) Raw Materials
Table 81. Non-steroidal Anti-inflammatory Drugs (NSAID) Raw Materials Suppliers in Global Market
Table 82. Typical Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream
Table 83. Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream Clients in Global Market
Table 84. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors and Sales Agents in Global Market
Table 1. Key Players of Non-steroidal Anti-inflammatory Drugs (NSAID) in Global Market
Table 2. Top Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Companies, 2017-2022
Table 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Companies, (K Units), 2017-2022
Table 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
Table 9. List of Global Tier 1 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2017-2022
Table 15. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2023-2028
Table 16. By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2017-2022
Table 20. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2023-2028
Table 21. By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2017-2022
Table 25. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2023-2028
Table 26. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2017-2022
Table 29. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2023-2028
Table 30. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2017-2022
Table 33. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2023-2028
Table 34. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2017-2022
Table 37. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2023-2028
Table 38. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2017-2022
Table 41. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2023-2028
Table 46. Bayer Corporate Summary
Table 47. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 48. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Ecotrin Corporate Summary
Table 50. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 51. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Generic Corporate Summary
Table 53. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 54. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. St. Joseph Corporate Summary
Table 56. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 57. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Elanco Corporate Summary
Table 59. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 60. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Zoetis Corporate Summary
Table 62. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 63. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Boehringer Ingelheim Corporate Summary
Table 65. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 66. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Merial Corporate Summary
Table 68. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 69. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Merck Animal Health Corporate Summary
Table 71. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 72. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 74. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production by Region, 2017-2022 (K Units)
Table 76. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production by Region, 2023-2028 (K Units)
Table 77. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Opportunities & Trends in Global Market
Table 78. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers in Global Market
Table 79. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints in Global Market
Table 80. Non-steroidal Anti-inflammatory Drugs (NSAID) Raw Materials
Table 81. Non-steroidal Anti-inflammatory Drugs (NSAID) Raw Materials Suppliers in Global Market
Table 82. Typical Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream
Table 83. Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream Clients in Global Market
Table 84. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Type
Figure 2. Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Application
Figure 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028 (US$, Mn)
Figure 7. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue in 2021
Figure 9. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
Figure 10. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
Figure 13. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
Figure 16. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
Figure 19. US Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
Figure 24. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 25. France Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
Figure 33. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 37. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
Figure 40. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
Figure 44. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Non-steroidal Anti-inflammatory Drugs (NSAID) by Region, 2021 VS 2028
Figure 50. Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Type
Figure 2. Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Application
Figure 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028 (US$, Mn)
Figure 7. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue in 2021
Figure 9. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
Figure 10. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
Figure 13. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
Figure 16. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
Figure 19. US Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
Figure 24. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 25. France Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
Figure 33. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 37. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
Figure 40. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
Figure 44. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Non-steroidal Anti-inflammatory Drugs (NSAID) by Region, 2021 VS 2028
Figure 50. Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Value Chain
Figure 51. Marketing Channels
